New updates have been reported about Oasys Health.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Oasys Health has secured a total of $4.6 million in early-stage funding to accelerate development and deployment of its AI-native operating system for behavioral health, positioning the company as an emerging infrastructure layer for data-driven mental health care. The financing includes a $4 million seed round led by Pathlight Ventures with participation from Twine Ventures and Better Ventures, and $600,000 in pre-seed capital from 1984 Ventures. Oasys plans to use the funds to enhance its AI platform, expand integrations with leading wearables and health apps, scale its engineering and data science teams, and deepen partnerships with health clinics, behavioral health centers, Managed Service Organizations, and educational institutions building long-term mental health capacity. CEO and co-founder Hashem Abdou said the company is targeting a structural shift in mental health delivery by turning historically subjective, session-based therapy into a continuous, measurable, and evidence-driven discipline through the combination of AI, unstructured clinical data, and real-time physiological signals from devices.
The Oasys platform unifies practice management, clinical decision support, and data from wearables such as Apple Watch, Oura Ring, Strava, and Flo to automate documentation, scribing, billing, scheduling, and insurance workflows while enabling remote patient monitoring and new reimbursement opportunities via RPM CPT codes. For behavioral health organizations, Oasys aims to reduce clinician burnout and operational friction by providing automation and real-time analytics on performance, outcomes, and site-level operations; clinicians are reporting time savings of more than 10 hours per week on administrative work, improved documentation accuracy, and earlier detection of risk signals. The company already partners with more than 25 clinics across the U.S., supporting hundreds of providers and thousands of patients, and is onboarding new clinics within 48 hours on a weekly cadence. Early users report higher patient engagement and adherence to symptom tracking, fewer claim denials, and faster reimbursement cycles. In 2026, Oasys plans to roll out a formal outcomes measurement framework to standardize how clinicians track progress and demonstrate therapy effectiveness over time, with an ambition to scale its footprint to more than 1,000 enterprise-grade mental health organizations that prioritize clinical precision, operational efficiency, and data-driven care.

